SiteALERT provides you with a customized report of which physicians are adopting and utilizing specific drugs and how regularly they are doing so. This enables you to take a closer look at previously unknown market potentials by tumor type, disease state, or drug sequencing to help you accurately adjust your marketing spend. 

And now, with biomarker data available for breast cancer and NSCLC, you can gain more precise insights into how testing influences treatment decisions. These insights support a shift from generalized treatment approaches to precision medicine—empowering physicians to tailor therapies to individual patients. With SiteALERT, you can strategically segment your outreach and deliver targeted messaging to the physicians most likely to prescribe your product.

SiteALERT Pro is your key to unleashing the power of your data. Designed for intuitive interaction, this tool helps you visualize and interact with your custom SiteALERT data in various report formats. Deepen your market understanding through detailed insights into your brand metrics for targeted messaging, precise call planning, and identifying new opportunities.

Discover your data's potential today.

Our customized reports include prescription claims of oral anti-cancer therapies and supportive care agents dispensed from members of our medically integrated dispensing program. Generated from a network of community practices, Specialty Dispensing Insights can help you develop a deeper understanding of individual physician prescribing patterns to enhance targeted education, sales, and marketing. Set your segments and cadence of reporting, and start turning data into action.